Biotech Boom: Uncovering Hidden Gems with Soaring Popularity
Investors are increasingly interested in companies like Galmed Pharmaceuticals, Protagenic Therapeutics, and Hepion Pharmaceuticals for their innovative approaches in biotech. Galmed Pharmaceuticals is developing Aramchol for liver and fibro-inflammatory diseases,…
Former Theranos CEO Elizabeth Holmes Quietly Supports New AI Health Startup from Prison
Elizabeth Holmes, former CEO of Theranos, remains influential in tech, advising Haemanthus from prison. Haemanthus, led by Billy Evans, aims to innovate medical testing using AI and Raman spectroscopy. Evans…
AI-Powered Biotech Startup Makes Strategic Cuts to Secure Future Amid Industry Challenges
Insitro is downsizing its workforce by 22%, reflecting broader industry challenges in biotech fundraising. Led by Daphne Koller, Insitro combines machine learning with drug discovery, serving as an innovation leader.…
Shareholders Unite: Shanghai Henlius Biotech Pushes Boundaries in Innovative Medicine
Shanghai Henlius Biotech is driving a quiet revolution in biotechnology from its base in Shanghai. The company recently held an Annual General Meeting, where all resolutions received strong shareholder approval,…
Is the U.S. Biotech Industry on the Verge of Losing Its Global Leadership?
President Trump's executive order on drug pricing fuels debate, potentially reshaping U.S. healthcare economics and impacting the biotech industry. The directive proposes significant cuts in Medicaid drug reimbursements, posing a…
Swiss Biotech Triumphs Amid Global Economic Headwinds: Here’s Why the World is Watching
Swiss biotech sector shows resilience and innovation amidst a challenging global economy, with a significant rise in R&D investment in 2024. In 2025, the Swiss Biotech Report reveals SFr2.6 billion…
The Unexpected Turn of Innovation: A Biotech Giant Announces Sweeping Layoffs
Arvinas, a biotech leader in New Haven, Connecticut, is renowned for innovative therapies aimed at combating serious diseases. The company announced a "mass layoff" affecting 131 employees, including 92 in…
The $1 Billion Biotech Bet: How Merck’s New Center Transforms Wilmington
Merck is establishing a $1 billion biologics center of excellence in Wilmington, Delaware, aiming to boost innovation and the local economy. The facility will focus on the production of Keytruda,…
Merck’s Ambitious $1B Bet on Wilmington: A Biotech Revolution Unfolds
Merck is investing $1 billion in a new biotechnological facility at Chestnut Run Innovation & Science Park in Wilmington, Delaware. The facility will manufacture Keytruda, a leading cancer therapy, significantly…
Unlock Community Growth with This Simple Yet Powerful Step
Small businesses are crucial to community vitality but face challenges in a changing world. Community members have an opportunity to support local businesses through participation in an online survey. The…